Industry & Services >> CEO Interviews >> October 3, 2011
Douglas W. Jamison is Chairman and Chief Executive Officer and a Managing Director of Harris & Harris Group, Inc., a publicly traded venture capital company. Mr. Jamison has previously held the positions of President, Chief Operating Officer and Chief Financial Officer of Harris & Harris Group, Inc. He is also currently Chairman and Chief Executive Officer of H&H Ventures Management, Inc., a wholly owned subsidiary of Harris & Harris Group, Inc. He is a member of the board of directors of HzO, Inc., and a board observer in ABSMaterials, Inc., Produced Water Absorbents, Inc., and Metabolon, Inc., privately held nanotechnology-enabled portfolio companies of Harris & Harris Group, Inc. Mr. Jamison was responsible for the company’s investment in Solazyme, Inc. prior to it going public in May 2011. He was also a member of the board of directors of Innovalight, Inc., prior to its acquisition by E.I. du Pont de Nemours and Company. Mr. Jamison is Co-Editor-in-Chief of Nanotechnology Law & Business. He is a member of the University of Pennsylvania Nano-Bio Interface Ethics Advisory Board, and a member of the Advisory Board, Massachusetts Technology Collaborative Nanotechnology Venture Forum. Prior to joining Harris & Harris Group, Inc., Mr. Jamison was a Senior Technology Manager at the University of Utah Technology Transfer Office, where he managed intellectual property in physics, chemistry and the engineering sciences. He is a graduate of Dartmouth College, B.A., 1992, and the University of Utah, M.S., 1999. Profile
TWST: Please begin with a brief overview of the history and evolution of Harris & Harris Group.
Mr. Jamison: Harris & Harris Group (TINY) was founded in 1983 by Mr. Charles Harris. Since our